Filing Details
- Accession Number:
- 0001209191-18-058568
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-11-14 17:11:18
- Reporting Period:
- 2018-11-12
- Accepted Time:
- 2018-11-14 17:11:18
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1124140 | Exact Sciences Corp | EXAS | Services-Commercial Physical & Biological Research (8731) | 204782291 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1367313 | S Katherine Zanotti | C/O Exact Sciences Corp. 441 Charmany Drive Madison WI 53719 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2018-10-31 | 3,411 | $0.00 | 102,786 | No | 5 | G | Direct | |
| Common Stock | Disposition | 2018-10-31 | 684 | $0.00 | 102,102 | No | 5 | G | Direct | |
| Common Stock | Acquisiton | 2018-11-12 | 7,667 | $3.43 | 109,769 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-11-12 | 7,667 | $69.00 | 102,102 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | G | Direct | |
| No | 5 | G | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2018-11-12 | 7,667 | $0.00 | 7,667 | $3.43 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2011-07-16 | 2020-07-16 | No | 4 | M | Direct |
Footnotes
- Represents shares of common stock received upon exercise of a stock option award.
- The sales reported in this field were effected pursuant to a Rule 10b5-1 trading plan.
Billionaire Hedge Funds
